欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-PI3K/Akt/mTOR Pathway-Akt-TAS0612
TAS0612

Chemical Structure : TAS0612

CAS No.: 2148902-58-1

TAS0612 (TAS-0612)

货号: PC-38198Not For Human Use, Lab Use Only.

TAS0612 (TAS-0612) is an orally bioavailable multikinase inhibitor of AKT, p70S6K, and p90RSK, inhibits Y-box-binding protein (YBX1) phosphorylation.

规格 价格 库存 数量
5 mg ¥2480 In stock
10 mg ¥3980 In stock
50 mg Get quote
100 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC) Select Batch:

生物&药学活性

TAS0612 (TAS-0612) is an orally bioavailable multikinase inhibitor of AKT, p70S6K, and p90RSK, inhibits Y-box-binding protein (YBX1) phosphorylation.
TAS0612 inhibits cell proliferation and suppresses the phosphorylation of YBX1 in TNBC cell lines, shows antitumor effect against antiestrogen-resistant cells and TNBC cells in vivo.
TAS0612 inhibited pYBX1, pPRAS40 and pS6 in ERα(+)/HER2(−) and ERα(−)/HER2(+) cell lines, the expression levels of pAKT, pp90RSK, and pp70S6K were increased following treatment with relatively higher doses of TAS0612.
TAS0612 showed potent antitumor effects and marked inhibition of pYBX1 and pS6 in the experimental therapeutic model of TNBC.

物理化学性质&存储条件

分子量 573.61
分子式 C27H34F3N9O2
外观性状 Solid
CAS No.
储存条件
固体粉末
-20°C 12 个月; 4°C 6 个月
配置液
-80°C 6 个月; -20°C 6 个月
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

4-(4-(3-((2-(tert-butylamino)ethyl)amino)-6-(5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)pyridin-2-yl)piperidin-1-yl)-5,5-dimethyl-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one

参考文献

1. Shibata T, et al. Mol Cancer Ther. 2020 Mar;19(3):882-894.

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: